Advanced search
Publication Cover
Postgraduate Medicine Volume 123, 2011 - Issue 1
Submit an article Journal homepage
14
Views
5
CrossRef citations to date
0
Altmetric
Clinical Focus: Metabolic Disorders, Diabetes, and Cardiovascular Disease

Differential Regulations of Lipid Profiles between Japanese Responders and Nonresponders Treated with Pioglitazone

Eiji Kutoh Division of Clinical Research, Biomedical Center, Tokyo, Japan; Division of Diabetes and Endocrinology, Department of Internal Medicine, Gyoda General Hospital, Saitama, JapanCorrespondence[email protected]
, MD, PhD
Pages 45-52 | Published online: 13 Mar 2015

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Eiji Kutoh, Asuka Wada, Alexandra N. Kuto, Jyunka Hayashi & Rumi Kurihara. (2020) Link between body weight changes and metabolic parameters in drugs naïve subjects with type 2 diabetes treated with canagliflozin monotherapy. Hospital Practice 48:2, pages 68-74.
Read now
Eiji Kutoh, Noriko Kaneoka & Mitsuru Hirate. (2015) Alogliptin: a new dipeptidyl peptidase-4 inhibitor with potential anti-atherogenic properties. Endocrine Research 40:2, pages 88-96.
Read now

Articles from other publishers (3)

Eiji Kutoh, Alexandra N. Kuto, Askuka Wada, Jyunka Hayashi & Rumi Kurihara. (2020) Sitagliptin as an Initial Therapy and Differential Regulations of Metabolic Parameters Depending on its Glycemic Response in Subjects with Type 2 Diabetes. Drug Research 71:03, pages 157-165.
Crossref
Eiji Kutoh, Asuka Wada, Teruma Murayama & Yui Takizawa. (2017) Canagliflozin as an Initial Therapy in Drug-Naïve Subjects with Type 2 Diabetes Mellitus: A Potential Involvement of Atherogenic Lipids in its Glycemic Efficacy. Drugs in R&D 17:2, pages 313-320.
Crossref
So Young HaHae Won JungYong Jun ChoiHyun Kyo LeeJong Wook ChoiJi Hoon ChoiJung Hyun NohJae Won HongDong-Jun Kim. (2016) Retrospective Observational Dose-Titration Study of Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on 15 mg of Pioglitazone. The Journal of Korean Diabetes 17:1, pages 51.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.